Ocean Biomedical Faces Delisting Concerns
Ticker: OCEA · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1869974
Sentiment: bearish
Topics: delisting, listing-standards, compliance
TL;DR
Ocean Biomedical might be delisted - stock exchange listing rules are a problem.
AI Summary
Ocean Biomedical, Inc. filed an 8-K on March 20, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates a potential transfer of listing, with the earliest event reported as March 14, 2025. The company is incorporated in Delaware and its principal executive offices are located at 515 Madison Ave, New York, NY.
Why It Matters
This filing signals potential issues with Ocean Biomedical's compliance with stock exchange listing requirements, which could impact its stock's tradability and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on an exchange.
Key Numbers
- 001-40793 — SEC File Number (Identifies the company's filing history with the SEC.)
- 87-1309280 — IRS Number (Company's Employer Identification Number.)
Key Players & Entities
- Ocean Biomedical, Inc. (company) — Registrant
- March 14, 2025 (date) — Earliest event reported
- March 20, 2025 (date) — Filing date
- 515 Madison Ave Suite 8078 (address) — Business and Mail Address
- New York, NY 10022 (address) — Business and Mail City, State, Zip
FAQ
What specific listing rule or standard has Ocean Biomedical, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Ocean Biomedical, Inc. has failed to satisfy, only that a notice has been issued.
What is the expected timeline for the potential transfer of listing?
The filing does not provide a specific timeline for the potential transfer of listing.
What are the implications of a delisting for Ocean Biomedical, Inc. shareholders?
Delisting typically means the stock can no longer be traded on major exchanges, potentially reducing liquidity and investor confidence, though it may trade on over-the-counter markets.
Has Ocean Biomedical, Inc. previously faced delisting warnings?
This specific 8-K filing does not contain information about previous delisting warnings.
What is the company's primary business as indicated by its SIC code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Ocean Biomedical, Inc. (OCEA).